Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis

---

Copy For Citation

Cansu B., Cansu D. U., Kasifoglu T., Gulbas Z., Korkmaz C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.17, no.1, pp.14-17, 2011 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 17 Issue: 1
• Publication Date: 2011
• Doi Number: 10.1097/rhu.0b013e318204a587
• Journal Name: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.14-17
• Kütahya Health Sciences University Affiliated: No

Abstract

Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).